Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Financial Statements
- Click here to download Medtronic Plc's Income Statement
- Click here to download Medtronic Plc's Balance Sheet
- Click here to download Medtronic Plc's Statement of Cash Flows
Key Info
- Industry: Medical Specialties
- Sector: Health Technology
- CEO Name: Geoffrey Straub Martha
Key Statistics
- Stock Price: $108.78
- Dividend Yield: 2.0%
- Market Capitalization: $146,123,086,200
- Shares Outstanding: 1,343,290,000
- Number of Employees: 90,000
- Trailing 12-Month EPS: $3.29
- Trailing 12-Month DPS: $2.2
- Payout Ratio: 66.9%
Important Dates
- Next Earnings Date: 2020-11-24
- Next Ex-Dividend Date: 2020-06-25
Price Trends
- Current Stock Price: $108.78
- 52-week high: $122.15
- 52-week low: $72.13
- 200-day moving average: $102.19
- 50-day moving average: $97.58
Performance
- 1-Month Price Return: 11.8%
- 3-Month Price Return: 12.0%
- 6-Month Price Return: 8.3%
- 1-Year Price Return: 1.2%
- 2-Year Price Return: 2.5%
- 5-Year Price Return: 16.1%
Visit the Passiv Stock Directory
Data provided by IEX Cloud